N. A. Novikova & A. S. Shilova. (2017). THE SPECIFICS OF PRESCRIBING TRIPLE ANTITROMBOTIC THERAPY WITH RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CORONARY ARTERY STENTING. «REMEDIUM GROUP» Ltd..
Chicago Style (17th ed.) CitationN. A. Novikova and A. S. Shilova. THE SPECIFICS OF PRESCRIBING TRIPLE ANTITROMBOTIC THERAPY WITH RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CORONARY ARTERY STENTING. «REMEDIUM GROUP» Ltd., 2017.
MLA (9th ed.) CitationN. A. Novikova and A. S. Shilova. THE SPECIFICS OF PRESCRIBING TRIPLE ANTITROMBOTIC THERAPY WITH RIVAROXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CORONARY ARTERY STENTING. «REMEDIUM GROUP» Ltd., 2017.
Warning: These citations may not always be 100% accurate.